Endometrial Cancer: Key Abstracts From SGO 2023 Endometrial Cancer: Key Abstracts From SGO 2023
Highlights on endometrial cancer from SGO 2023 include two phase 3 studies examining chemo plus immunotherapy combinations that may prove to be practice-changing in advanced and recurrent disease.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news
More News: Cancer | Cancer & Oncology | Endometrial Cancer | Health | Hematology | Immunotherapy | Study